Mobiluncus mulieris Details: NCBI 2052, high G+C gram-positive [species]

Found in Oral Cavity

For the possible significance see Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes, 2024

---

| ATCC 35243| ATCC 43064 [[Falcivibrio grandis Hammann et al. 1984]]| CCM 3743 [[Falcivibrio grandis Hammann et al. 1984]]| CCUG 20071| CNCTC An 18/88 [[Falcivibrio grandis Hammann et al. 1984]]| DSM 25311| DSM 2710 [[Falcivibrio grandis Hammann et al. 1984]]| Falcivibrio grandis| Falcivibrio grandis Hammann et al. 1984| LMG 7787| LMG 7855 [[Falcivibrio grandis Hammann et al. 1984]]| LMG:7787| LMG:7855 [[Falcivibrio grandis Hammann et al. 1984]]| Mobiluncus mulieris| Mobiluncus mulieris Spiegel and Roberts 1984 emend. Hoyles et al. 2004| NCTC 11658| NCTC 11819 [[Falcivibrio grandis Hammann et al. 1984]]| strain Hammann L23-1b [[Falcivibrio grandis Hammann et al. 1984]]| strain L23-1b [[Falcivibrio grandis Hammann et al. 1984]]| strain SV17J

1. Antibiotic Production: Streptomyces lincolnensis produces lincomycin, a lincosamide antibiotic. Lincomycin is effective against a wide range of Gram-positive bacteria, including staphylococci, streptococci, and anaerobic bacteria. It is used clinically to treat various infections, including skin and soft tissue infections, respiratory tract infections, and infections caused by anaerobic bacteria.

2. Clinical Applications: Lincomycin, produced by Streptomyces lincolnensis, has been used clinically for many years to treat bacterial infections in humans and animals. However, its use is now more limited due to the availability of other antibiotics and concerns about antibiotic resistance and side effects.

3. Antibiotic Resistance Studies: Streptomyces lincolnensis and its antibiotic, lincomycin, have been studied in the context of antibiotic resistance. Understanding the mechanisms of action and resistance to lincomycin can provide insights into combating antibiotic resistance in bacteria.

4. Biotechnological Applications: Lincomycin and its derivatives may have various biotechnological applications beyond medicine. They may be used in agriculture as growth promoters for livestock or in industry for the production of semi-synthetic antibiotics.

5. Environmental Health: Streptomyces lincolnensis, like other Streptomyces species, plays roles in soil ecology and nutrient cycling, which indirectly impact human health through ecosystem services such as soil fertility and environmental sustainability.

Visuals of Interactions with other bacteria of the same rank

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

• Immune Epitope Database
• The NCBI taxonomy database
• UniProt
• Immune Epitope Taxonomy Database (IEDB)
• AI Engines For more Details: Perplexity  Kagi Labs  You 

More Information

Statistics

NCBI

Data Punk

End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Mobiluncus mulieris

• Frequency - how often do samples show this bacteria
• UD - An alternative statistical algorithm (which factors in the frequency)
• Kaltoft-Moldrup Heuristic Using uploaded data
• Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation

These are values that are computed from lab specific samples (Patent Pending)

Lab	Frequency	UD-Low	UD-High	KM Low	KM High	Lab Low	Lab High	Mean	Median	Standard Deviation	Box Plot Low	Box Plot High	KM Percentile Low	KM Percentile High
Other Labs	0.04			0	20			20	20		20	20	0 %ile	99 %ile
biomesight	0.88			10	130	0	96	32.9	20	32.3	0	60	0 %ile	100 %ile
ubiome	2.92			20	2831	0	1453	254.8	58	611.2	14	240	0 %ile	100 %ile

External Reference Ranges for Mobiluncus mulieris

Mobiluncus mulieris (NCBI 2052) per million

Source of Ranges	Low Boundary	High Boundary	Low Boundary %age	High Boundary %age

Statistic by Lab Source for Mobiluncus mulieris

These desired values are reported from the lab reports

Lab	Frequency Seen	Average	Standard Deviation	Sample Count	Lab Samples
BiomeSight	0.817 %	0.005 %	0.005 %	38.0	4653
BiomeSightRdp	3.226 %	0.002 %	%	1.0	31
custom	5.263 %	0.001 %	0.001 %	4.0	76
uBiome	2.868 %	0.025 %	0.061 %	23.0	802

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

• If I want to know that a substance also changes, then I just click on it
• If I want to know which study this information comes from, then I just clink in increases or decreases

Data Contradictions — Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

🧙? Search Hints:

General Substance	Specific Substance	Effect
Probiotics	Finnish Probiotic {Valio Probiotic}	1 Studies recorded. The consensus is Increases📓, Click for details.